Cargando…
Clinical Decision Support Systems in Breast Cancer: A Systematic Review
Breast cancer is the most frequently diagnosed cancer in women, with more than 2.1 million new diagnoses worldwide every year. Personalised treatment is critical to optimising outcomes for patients with breast cancer. A major advance in medical practice is the incorporation of Clinical Decision Supp...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072392/ https://www.ncbi.nlm.nih.gov/pubmed/32041094 http://dx.doi.org/10.3390/cancers12020369 |
_version_ | 1783506395760427008 |
---|---|
author | Mazo, Claudia Kearns, Cathriona Mooney, Catherine Gallagher, William M. |
author_facet | Mazo, Claudia Kearns, Cathriona Mooney, Catherine Gallagher, William M. |
author_sort | Mazo, Claudia |
collection | PubMed |
description | Breast cancer is the most frequently diagnosed cancer in women, with more than 2.1 million new diagnoses worldwide every year. Personalised treatment is critical to optimising outcomes for patients with breast cancer. A major advance in medical practice is the incorporation of Clinical Decision Support Systems (CDSSs) to assist and support healthcare staff in clinical decision-making, thus improving the quality of decisions and overall patient care whilst minimising costs. The usage and availability of CDSSs in breast cancer care in healthcare settings is increasing. However, there may be differences in how particular CDSSs are developed, the information they include, the decisions they recommend, and how they are used in practice. This systematic review examines various CDSSs to determine their availability, intended use, medical characteristics, and expected outputs concerning breast cancer therapeutic decisions, an area that is known to have varying degrees of subjectivity in clinical practice. Utilising the methodology of Kitchenham and Charter, a systematic search of the literature was performed in Springer, Science Direct, Google Scholar, PubMed, ACM, IEEE, and Scopus. An overview of CDSS which supports decision-making in breast cancer treatment is provided along with a critical appraisal of their benefits, limitations, and opportunities for improvement. |
format | Online Article Text |
id | pubmed-7072392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70723922020-03-19 Clinical Decision Support Systems in Breast Cancer: A Systematic Review Mazo, Claudia Kearns, Cathriona Mooney, Catherine Gallagher, William M. Cancers (Basel) Review Breast cancer is the most frequently diagnosed cancer in women, with more than 2.1 million new diagnoses worldwide every year. Personalised treatment is critical to optimising outcomes for patients with breast cancer. A major advance in medical practice is the incorporation of Clinical Decision Support Systems (CDSSs) to assist and support healthcare staff in clinical decision-making, thus improving the quality of decisions and overall patient care whilst minimising costs. The usage and availability of CDSSs in breast cancer care in healthcare settings is increasing. However, there may be differences in how particular CDSSs are developed, the information they include, the decisions they recommend, and how they are used in practice. This systematic review examines various CDSSs to determine their availability, intended use, medical characteristics, and expected outputs concerning breast cancer therapeutic decisions, an area that is known to have varying degrees of subjectivity in clinical practice. Utilising the methodology of Kitchenham and Charter, a systematic search of the literature was performed in Springer, Science Direct, Google Scholar, PubMed, ACM, IEEE, and Scopus. An overview of CDSS which supports decision-making in breast cancer treatment is provided along with a critical appraisal of their benefits, limitations, and opportunities for improvement. MDPI 2020-02-06 /pmc/articles/PMC7072392/ /pubmed/32041094 http://dx.doi.org/10.3390/cancers12020369 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mazo, Claudia Kearns, Cathriona Mooney, Catherine Gallagher, William M. Clinical Decision Support Systems in Breast Cancer: A Systematic Review |
title | Clinical Decision Support Systems in Breast Cancer: A Systematic Review |
title_full | Clinical Decision Support Systems in Breast Cancer: A Systematic Review |
title_fullStr | Clinical Decision Support Systems in Breast Cancer: A Systematic Review |
title_full_unstemmed | Clinical Decision Support Systems in Breast Cancer: A Systematic Review |
title_short | Clinical Decision Support Systems in Breast Cancer: A Systematic Review |
title_sort | clinical decision support systems in breast cancer: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072392/ https://www.ncbi.nlm.nih.gov/pubmed/32041094 http://dx.doi.org/10.3390/cancers12020369 |
work_keys_str_mv | AT mazoclaudia clinicaldecisionsupportsystemsinbreastcancerasystematicreview AT kearnscathriona clinicaldecisionsupportsystemsinbreastcancerasystematicreview AT mooneycatherine clinicaldecisionsupportsystemsinbreastcancerasystematicreview AT gallagherwilliamm clinicaldecisionsupportsystemsinbreastcancerasystematicreview |